These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 18229435

  • 1. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
    Burman W, Weis S, Vernon A, Khan A, Benator D, Jones B, Silva C, King B, LaHart C, Mangura B, Weiner M, El-Sadr W.
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1282-9. PubMed ID: 18229435
    [Abstract] [Full Text] [Related]

  • 2. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S.
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W, Likanonsakul S, Thawornwan U, Kongsanan P, Kittikraisak W, Burapat C, Akksilp S, Sattayawuthipong W, Srinak C, Nateniyom S, Tasaneeyapan T, Varma JK.
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [Abstract] [Full Text] [Related]

  • 4. A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy.
    Vallabhaneni S, Kumarasamy N, Wing EJ, Flanigan TP.
    AIDS Read; 2005 Feb; 15(2):72-5. PubMed ID: 15712396
    [Abstract] [Full Text] [Related]

  • 5. Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
    Loeliger A, Suthar AB, Ripin D, Glaziou P, O'Brien M, Renaud-Thery F, Crowley S, Williams B, Ridzon R, Granich R, Gilks C.
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):6-15. PubMed ID: 21819645
    [Abstract] [Full Text] [Related]

  • 6. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children.
    Zampoli M, Kilborn T, Eley B.
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):417-23. PubMed ID: 17394688
    [Abstract] [Full Text] [Related]

  • 7. Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.
    Tansuphasawadikul S, Saito W, Kim J, Phonrat B, Dhitavat J, Chamnachanan S, Pitisuttithum P.
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1053-60. PubMed ID: 18613546
    [Abstract] [Full Text] [Related]

  • 8. Progressive symptoms and signs following institution of highly active antiretroviral therapy and subsequent antituberculosis therapy: immune reconstitution syndrome or infection?
    Miller RF, Shahmanesh M, Talbot MD, Wiselka MJ, Shaw PJ, Bacon C, Robertson CM.
    Sex Transm Infect; 2006 Apr; 82(2):111-6. PubMed ID: 16581733
    [Abstract] [Full Text] [Related]

  • 9. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.
    Colebunders R, John L, Huyst V, Kambugu A, Scano F, Lynen L.
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):946-53. PubMed ID: 16964782
    [Abstract] [Full Text] [Related]

  • 10. HIV infection-related tuberculosis: clinical manifestations and treatment.
    Sterling TR, Pham PA, Chaisson RE.
    Clin Infect Dis; 2010 May 15; 50 Suppl 3():S223-30. PubMed ID: 20397952
    [Abstract] [Full Text] [Related]

  • 11. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX, CAMELIA (ANRS 1295 – CIPRA KH001) Study Team.
    AIDS; 2013 Oct 23; 27(16):2577-86. PubMed ID: 24096631
    [Abstract] [Full Text] [Related]

  • 12. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis.
    Swaminathan S, Padmapriyadarsini C, Narendran G, Thomas BE, Anand S, Rajyalakshmi A.
    Indian J Chest Dis Allied Sci; 2005 Oct 23; 47(4):299-304. PubMed ID: 16255403
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A, Johnson JL, Vjecha MJ, Wolski K, Whalen CC, Hom D, Huebner R, Mugerwa RD, Ellner JJ.
    Int J Tuberc Lung Dis; 1997 Oct 23; 1(5):441-5. PubMed ID: 9441099
    [Abstract] [Full Text] [Related]

  • 14. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis.
    Cheng SL, Wang HC, Yang PC.
    Int J Tuberc Lung Dis; 2007 Dec 23; 11(12):1290-5. PubMed ID: 18034948
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran.
    Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, Alipanah N, Emami H, Novin A, Mansouri D, Masjedi MR, Velayati AA.
    Saudi Med J; 2008 Jan 23; 29(1):148-50. PubMed ID: 18176695
    [No Abstract] [Full Text] [Related]

  • 16. Tuberculosis in HIV-infected patients: a comprehensive review.
    Aaron L, Saadoun D, Calatroni I, Launay O, Mémain N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O.
    Clin Microbiol Infect; 2004 May 23; 10(5):388-98. PubMed ID: 15113314
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA, Tuberculosis Trials Consortium.
    Pharmacotherapy; 2007 Jun 23; 27(6):793-800. PubMed ID: 17542762
    [Abstract] [Full Text] [Related]

  • 18. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 Mar 15; 51(10):214-5. PubMed ID: 11922192
    [Abstract] [Full Text] [Related]

  • 19. [Tuberculosis and HIV co-infection: a therapeutic challenge].
    Charbonnier F, Calmy A, Janssens JP.
    Rev Med Suisse; 2011 Nov 23; 7(318):2295-6, 2298-300. PubMed ID: 22400365
    [Abstract] [Full Text] [Related]

  • 20. Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.
    Català L, Orcau A, García de Olalla P, Millet JP, Rodríguez-Mondragón A, Caylà JA, TB-HIV Working Group.
    Int J Tuberc Lung Dis; 2011 Feb 23; 15(2):263-9, i. PubMed ID: 21219692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.